NYSE-listed Stryker, a provider of MedTech products and services, is acquiring Switzerland-based ZuriMED, a privately held company and developer of the FiberLocker System – technology that provides a novel approach for rotator cuff augmentation with increased biomechanical strength to address a key clinical failure mode in rotator cuff repair.
The acquisition will enhance Stryker’s ability to support shoulder specialists across both sports medicine and arthroplasty, strengthening its portfolio in rotator cuff augmentation.
“ZuriMED has developed a differentiated technology that addresses an important clinical need within shoulder care,” said Andy Pierce, group president, MedSurg and Neurotechnology, Stryker.
ZuriMED spun off from the University of Zurich and ETH Zurich in 2015 and was supported by Swiss VC, Balgrist Beteiligungs.
